Global Latent TB Testing Market Size Study, by Test Type, Application (Household Contacts of Tuberculosis Patients, People Living with HIV), End User and Regional Forecasts 2022-2032

Description

The Global Latent TB Testing Market is valued at approximately USD 550.57 million in 2023 and is poised to grow at a healthy CAGR of 5.80% during the forecast period 2024-2032. Latent tuberculosis (TB) testing serves as a cornerstone in global public health strategies, enabling early detection of dormant infections to curb the progression of active TB. Leveraging advanced diagnostic technologies, such as the Tuberculin Skin Test (TST) and Interferon-Gamma Release Assays (IGRA), latent TB testing plays a critical role in addressing disease control challenges, especially in high-risk populations. With the increasing prevalence of TB among immunocompromised individuals and rising investments in healthcare infrastructure, the latent TB testing market is witnessing notable advancements and adoption.

The surge in demand for latent TB testing is primarily fueled by the growing global burden of tuberculosis and the critical need for early-stage detection to mitigate the spread of this infectious disease. Technological innovations in diagnostics have enhanced the sensitivity and accuracy of latent TB tests, fostering their adoption across diverse clinical settings. For instance, IGRA tests, which offer more specific results than conventional methods, are increasingly favored by healthcare providers. However, the high cost of advanced tests and limited accessibility in resource-constrained regions may impede market expansion, particularly in developing economies.

The market is diversified in its application across vulnerable groups, such as household contacts of active TB patients and people living with HIV, where latent TB infection poses significant health risks. Diagnostic labs and hospitals serve as primary end users, relying on latent TB tests to implement targeted prevention and treatment protocols. These tests not only help in identifying at-risk individuals but also contribute to reducing healthcare costs associated with managing active TB cases. The evolving emphasis on personalized healthcare and integration of AI-driven diagnostic tools further enriches the market's potential for growth.

Regionally, North America dominates the latent TB testing market, underpinned by robust healthcare systems, advanced diagnostic infrastructure, and favorable government policies supporting TB control initiatives. The United States leads the region, benefiting from extensive R&D investments and high awareness levels among healthcare providers. Europe closely follows, driven by stringent public health guidelines and increasing adoption of innovative diagnostic solutions. The Asia-Pacific region is projected to witness the fastest growth, fueled by a high TB burden, rising healthcare spending, and government-led programs to combat the disease. Emerging regions such as Latin America and the Middle East & Africa are gradually adopting latent TB testing to address endemic TB challenges and improve public health outcomes.

Major market players included in this report are:

QIAGEN
Oxford Immunotec Global PLC
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd
Abbott Laboratories
Becton, Dickinson and Company
bioMerieux SA
Hain Lifescience GmbH
Cepheid
Siemens Healthineers AG
Lonza Group
GenScript Biotech Corporation
Creative Diagnostics
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.

The detailed segments and sub-segments of the market are explained below:

By Test Type:

Tuberculin Skin Test (TST)
IGRA Test

By Application:

Household Contacts (HHC) of Tuberculosis (TB) Patients
People Living with HIV

By End User:

Diagnostic Labs
Hospitals

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
India
Japan
Australia
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Years considered for the study are as follows:

Historical Year: 2022
Base Year: 2023
Forecast Period: 2024 to 2032

Key Takeaways:

Comprehensive market estimates and forecasts spanning 10 years.
Segmental insights highlighting test type, application, and end-user trends.
Detailed analysis of regional market dynamics and growth opportunities.
In-depth evaluation of market drivers, challenges, and emerging trends.
Competitive profiling of leading players with insights into their strategic initiatives.

Chapter 1. Global Latent TB Testing Market Executive Summary

1.1. Global Latent TB Testing Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Test Type
- 1.3.2. By Application
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Latent TB Testing Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory Frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Latent TB Testing Market Dynamics

3.1. Market Drivers
- 3.1.1. Growing Global Burden of Tuberculosis
- 3.1.2. Technological Innovations Enhancing Test Accuracy
- 3.1.3. Increasing Prevalence among Immunocompromised Individuals
3.2. Market Challenges
- 3.2.1. High Cost of Advanced Diagnostic Tests
- 3.2.2. Limited Accessibility in Resource-Constrained Regions
3.3. Market Opportunities
- 3.3.1. Government Initiatives and Funding for TB Control
- 3.3.2. Integration of AI-Driven Diagnostic Tools
- 3.3.3. Expansion into Emerging Markets with High TB Prevalence

Chapter 4. Global Latent TB Testing Market Industry Analysis

4.1. Porter's Five Forces Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's Five Forces Model
- 4.1.7. Porter's Five Forces Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economic
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Latent TB Testing Market Size & Forecasts by Test Type 2022-2032

5.1. Segment Dashboard
5.2. Global Latent TB Testing Market: By Test Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 5.2.1. Tuberculin Skin Test (TST)
- 5.2.2. IGRA Test

Chapter 6. Global Latent TB Testing Market Size & Forecasts by Application 2022-2032

6.1. Segment Dashboard
6.2. Global Latent TB Testing Market: By Application Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 6.2.1. Household Contacts (HHC) of Tuberculosis (TB) Patients
- 6.2.2. People Living with HIV

Chapter 7. Global Latent TB Testing Market Size & Forecasts by End User 2022-2032

7.1. Segment Dashboard
7.2. Global Latent TB Testing Market: By End User Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 7.2.1. Diagnostic Labs
- 7.2.2. Hospitals

Chapter 8. Global Latent TB Testing Market Size & Forecasts by Region 2022-2032

8.1. North America Latent TB Testing Market
- 8.1.1. U.S. Latent TB Testing Market
  - 8.1.1.1. By Test Type Breakdown Size & Forecasts, 2022-2032
  - 8.1.1.2. By Application Breakdown Size & Forecasts, 2022-2032
- 8.1.2. Canada Latent TB Testing Market
  - 8.1.2.1. By Test Type Breakdown Size & Forecasts, 2022-2032
  - 8.1.2.2. By Application Breakdown Size & Forecasts, 2022-2032
8.2. Europe Latent TB Testing Market
- 8.2.1. UK Latent TB Testing Market
  - 8.2.1.1. By Test Type Breakdown Size & Forecasts, 2022-2032
  - 8.2.1.2. By Application Breakdown Size & Forecasts, 2022-2032
- 8.2.2. Germany Latent TB Testing Market
  - 8.2.2.1. By Test Type Breakdown Size & Forecasts, 2022-2032
  - 8.2.2.2. By Application Breakdown Size & Forecasts, 2022-2032
- 8.2.3. France Latent TB Testing Market
  - 8.2.3.1. By Test Type Breakdown Size & Forecasts, 2022-2032
  - 8.2.3.2. By Application Breakdown Size & Forecasts, 2022-2032
- 8.2.4. Spain Latent TB Testing Market
  - 8.2.4.1. By Test Type Breakdown Size & Forecasts, 2022-2032
  - 8.2.4.2. By Application Breakdown Size & Forecasts, 2022-2032
- 8.2.5. Italy Latent TB Testing Market
  - 8.2.5.1. By Test Type Breakdown Size & Forecasts, 2022-2032
  - 8.2.5.2. By Application Breakdown Size & Forecasts, 2022-2032
- 8.2.6. Rest of Europe Latent TB Testing Market
8.3. Asia-Pacific Latent TB Testing Market
- 8.3.1. China Latent TB Testing Market
  - 8.3.1.1. By Test Type Breakdown Size & Forecasts, 2022-2032
  - 8.3.1.2. By Application Breakdown Size & Forecasts, 2022-2032
- 8.3.2. India Latent TB Testing Market
  - 8.3.2.1. By Test Type Breakdown Size & Forecasts, 2022-2032
  - 8.3.2.2. By Application Breakdown Size & Forecasts, 2022-2032
- 8.3.3. Japan Latent TB Testing Market
  - 8.3.3.1. By Test Type Breakdown Size & Forecasts, 2022-2032
  - 8.3.3.2. By Application Breakdown Size & Forecasts, 2022-2032
- 8.3.4. Australia Latent TB Testing Market
  - 8.3.4.1. By Test Type Breakdown Size & Forecasts, 2022-2032
  - 8.3.4.2. By Application Breakdown Size & Forecasts, 2022-2032
- 8.3.5. South Korea Latent TB Testing Market
  - 8.3.5.1. By Test Type Breakdown Size & Forecasts, 2022-2032
  - 8.3.5.2. By Application Breakdown Size & Forecasts, 2022-2032
- 8.3.6. Rest of Asia-Pacific Latent TB Testing Market
8.4. Latin America Latent TB Testing Market
- 8.4.1. Brazil Latent TB Testing Market
  - 8.4.1.1. By Test Type Breakdown Size & Forecasts, 2022-2032
  - 8.4.1.2. By Application Breakdown Size & Forecasts, 2022-2032
- 8.4.2. Mexico Latent TB Testing Market
  - 8.4.2.1. By Test Type Breakdown Size & Forecasts, 2022-2032
  - 8.4.2.2. By Application Breakdown Size & Forecasts, 2022-2032
- 8.4.3. Rest of Latin America Latent TB Testing Market
8.5. Middle East & Africa Latent TB Testing Market
- 8.5.1. Saudi Arabia Latent TB Testing Market
  - 8.5.1.1. By Test Type Breakdown Size & Forecasts, 2022-2032
  - 8.5.1.2. By Application Breakdown Size & Forecasts, 2022-2032
- 8.5.2. South Africa Latent TB Testing Market
  - 8.5.2.1. By Test Type Breakdown Size & Forecasts, 2022-2032
  - 8.5.2.2. By Application Breakdown Size & Forecasts, 2022-2032
- 8.5.3. Rest of Middle East & Africa Latent TB Testing Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
- 9.1.1. QIAGEN
- 9.1.2. Oxford Immunotec Global PLC
- 9.1.3. Thermo Fisher Scientific Inc.
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. QIAGEN
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Market Strategies
- 9.3.2. Oxford Immunotec Global PLC
- 9.3.3. Thermo Fisher Scientific Inc.
- 9.3.4. F. Hoffmann-La Roche Ltd
- 9.3.5. Abbott Laboratories
- 9.3.6. Becton, Dickinson and Company
- 9.3.7. bioMerieux SA
- 9.3.8. Hain Lifescience GmbH
- 9.3.9. Cepheid
- 9.3.10. Siemens Healthineers AG
- 9.3.11. Lonza Group
- 9.3.12. GenScript Biotech Corporation
- 9.3.13. Creative Diagnostics
- 9.3.14. Beckman Coulter, Inc.
- 9.3.15. Bio-Rad Laboratories, Inc.

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes